Zydus Lifesciences Ltd
NSE :ZYDUSLIFE BSE :532321 Sector : PharmaceuticalsBuy, Sell or Hold ZYDUSLIFE? Ask The Analyst
BSE
prev close
OPEN PRICE
volume
Today's low / high
52 WK low / high
bid price (qty)
offer price (qty)
NSE
prev close
open price
volume
Today's' low / high
52 WK low / high
bid price (qty)
offer price (qty)
22 May 903.45 (1.55%) | 21 May 889.65 (0.72%) | 20 May 883.30 (-3.07%) | 19 May 911.25 (0.95%) | 16 May 902.70 (-0.22%) | 15 May 904.70 (0.13%) | 14 May 903.50 (0.18%) | 13 May 901.85 (1.92%) | 12 May 884.85 (0.71%) | 09 May 878.65 (0.57%) | 08 May 873.70 (-1.40%) | 07 May 886.15 (0.62%) | 06 May 880.65 (-1.33%) | 05 May 892.50 (0.78%) | 02 May 885.60 (-0.30%) | 30 Apr 888.25 (0.02%) | 29 Apr 888.05 (0.17%) | 28 Apr 886.55 (3.13%) | 25 Apr 859.65 (-2.34%) | 24 Apr 880.25 (1.41%) | 23 Apr 868.00 (1.79%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors

Very Bullish
Medium Term Investors

Very Bullish
Long Term Investors

Bearish
Moving Averages
5 DMA
Bullish
898.16
10 DMA
Bullish
896.35
20 DMA
Bullish
889.01
50 DMA
Bullish
885.24
100 DMA
Bearish
918.12
200 DMA
Bearish
987.8
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On May 22, 2025 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 935.66 | 923.58 | 909.54 | - | - |
R2 | 923.58 | 915.12 | 907.51 | 924.09 | - |
R1 | 913.51 | 909.89 | 905.48 | 914.53 | 918.55 |
P | 901.43 | 901.43 | 901.43 | 901.94 | 903.95 |
S1 | 891.36 | 892.97 | 901.42 | 892.38 | 896.4 |
S2 | 879.28 | 887.74 | 899.39 | 879.79 | - |
S3 | 869.21 | 879.28 | 897.36 | - | - |
Key Metrics
EPS
57.39
P/E
15.75
P/B
4.29
Dividend Yield
1.22%
Market Cap
90,908 Cr.
Face Value
1
Book Value
210.59
ROE
20.64%
EBITDA Growth
1,985.5 Cr.
Debt/Equity
0.05
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Zydus Lifesciences Ltd Quaterly Results
Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | ||
INCOME | 5693.4 | 6270.7 | 5305.5 | 5326.6 | 6608.5 | |
PROFIT | 1179.1 | 1419.9 | 910.9 | 1023.8 | 1260.39 | |
EPS | 11.69 | 14.11 | 9.06 | 10.17 | 11.64 |
Zydus Lifesciences Ltd Quaterly Results
Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | ||
INCOME | 3693.5 | 4266.8 | 2947.3 | 2593.4 | 6005 | |
PROFIT | 1411.72 | 1700.8 | 789.8 | 470.6 | 2813.7 | |
EPS | 13.89 | 16.9 | 7.85 | 4.68 | 27.96 |
Profit & Loss (Figures in Rs. Crores)
Zydus Lifesciences Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 8804.1 | 9553.5 | 9643.7 | 12333.5 | 13476.4 | 14460.8 | 14605.3 | 18055.3 | 17185.9 | 20108.2 | |
PROFIT | 1157.11 | 1936.48 | 1488.67 | 1743.64 | 1793 | 1473.53 | 2369.75 | 4387.47 | 2387.89 | 3860.05 | |
EPS | 10.9 | 18.76 | 14.48 | 17.07 | 18.08 | 11.48 | 20.87 | 44.65 | 19.74 | 38.31 |
Zydus Lifesciences Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 5545.6 | 7156.7 | 3960.8 | 6204.7 | 6728.6 | 7240.6 | 8017.6 | 8062.5 | 9174.9 | 12035.2 | |
PROFIT | 1270.15 | 2038.39 | 662.54 | 1056.56 | 1411.26 | 1465.57 | 1633.15 | 1095.54 | 1621.47 | 3437.6 | |
EPS | 11.97 | 19.9 | 6.45 | 10.65 | 14.51 | 13.8 | 14.42 | 8.38 | 15.11 | 34.21 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 100.6 | 101.2 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 |
Reserves Total | 19,728.9 | 17,414.6 | 16,897.2 | 12,889.9 | 10,273.3 | 10,283.9 | 8,642.1 | 6,857.6 | 5,596.8 | 4,149.2 |
Total Shareholders Funds | 19,829.5 | 17,515.8 | 16,999.6 | 12,992.3 | 10,375.7 | 10,386.3 | 8,744.5 | 6,960 | 5,699.2 | 4,251.6 |
Minority Interest | 2,272.1 | 2,172.5 | 2,054.2 | 1,937.3 | 1,334.7 | 1,292.9 | 191 | 156.1 | 135.8 | 168.9 |
Secured Loans | 0 | 0 | 500 | 383.9 | 1,873.2 | 2,585.7 | 481.2 | 1,197 | 689.8 | 1,169.1 |
Unsecured Loans | 804.2 | 1,194.9 | 3,720.9 | 4,223.7 | 6,113.2 | 5,313.7 | 4,925.5 | 4,010.2 | 1,752.2 | 1,482.2 |
Total Debt | 804.2 | 1,194.9 | 4,220.9 | 4,607.6 | 7,986.4 | 7,899.4 | 5,406.7 | 5,207.2 | 2,442 | 2,651.3 |
Other Liabilities | 1,367.9 | 327.2 | 382.8 | 349.5 | 282.3 | 259.4 | 209.6 | 214 | 157.3 | 132.5 |
Total Liabilities | 24,273.7 | 21,210.4 | 23,657.5 | 19,886.7 | 19,979.1 | 19,838 | 14,551.8 | 12,537.3 | 8,434.3 | 7,204.3 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 19,919.8 | 18,343.8 | 17,650.9 | 17,345 | 16,781.5 | 15,702.3 | 9,349.1 | 8,102.9 | 5,767.3 | 5,138.5 |
Less: Accumulated Depreciation | 7,551.3 | 6,822.9 | 5,462.4 | 5,212.2 | 4,551 | 3,538.6 | 2,866.5 | 2,347.8 | 2,019.4 | 1,786.3 |
Net Block | 12,368.5 | 11,520.9 | 12,188.5 | 12,132.8 | 12,230.5 | 12,163.7 | 6,482.6 | 5,755.1 | 3,747.9 | 3,352.2 |
Capital Work in Progress | 2,423.3 | 1,200.7 | 725.9 | 783.2 | 741.5 | 837.2 | 1,527.2 | 1,543.3 | 950.8 | 797.9 |
Investments | 1,220.5 | 1,546.6 | 3,288 | 830.1 | 765 | 673.5 | 745.7 | 434.8 | 416.2 | 154.4 |
Inventories | 3,441.9 | 3,413.3 | 3,719.4 | 3,236.2 | 2,789 | 2,688 | 2,385.3 | 1,803.7 | 1,337.1 | 1,535.7 |
Sundry Debtors | 5,220.2 | 4,416.8 | 3,340.3 | 3,127.3 | 3,663.2 | 3,950.8 | 3,206.3 | 2,277.5 | 1,746.6 | 1,588.4 |
Cash and Bank Balance | 1,105.1 | 573.1 | 1,106.9 | 888.3 | 964.9 | 548.9 | 1,314.9 | 1,543.5 | 638.7 | 669.9 |
Loans and Advances | 1,400.1 | 985.7 | 1,575.4 | 1,265.3 | 1,085.5 | 1,080.5 | 1,048.4 | 348.5 | 358.9 | 311.5 |
Total Current Assets | 11,167.3 | 9,388.9 | 9,742 | 8,517.1 | 8,502.6 | 8,268.2 | 7,954.9 | 5,973.2 | 4,081.3 | 4,105.5 |
Current Liabilities | 3,793.8 | 3,829.4 | 3,576.7 | 3,460 | 3,225.3 | 3,203.4 | 3,079.2 | 2,498.1 | 1,834.1 | 1,398.8 |
Provisions | 766.8 | 522.2 | 407.4 | 418.3 | 272.3 | 189.4 | 152.2 | 68.9 | 81.3 | 382.5 |
Total Current Liabilities & Provisions | 4,560.6 | 4,351.6 | 3,984.1 | 3,878.3 | 3,497.6 | 3,392.8 | 3,231.4 | 2,567 | 1,915.4 | 1,784.2 |
Net Current Assets | 6,606.7 | 5,037.3 | 5,757.9 | 4,638.8 | 5,005 | 4,875.4 | 4,723.5 | 3,406.2 | 2,165.9 | 2,321.3 |
Deferred Tax Assets | 4,261.9 | 3,121.4 | 1,330.9 | 2,820.1 | 1,316.3 | 1,775.7 | 2,374.1 | 2,325.6 | 518.5 | 182.9 |
Deferred Tax Liability | 3,064.2 | 2,053.4 | 388.9 | 1,865.4 | 673.3 | 1,057.7 | 1,731.6 | 1,546.5 | 200.9 | 241.5 |
Net Deferred Tax | 1,197.7 | 1,068 | 942 | 954.7 | 643 | 718 | 642.5 | 779.1 | 317.6 | -58.6 |
Other Assets | 457 | 836.9 | 755.2 | 547.1 | 594.1 | 570.2 | 430.3 | 618.8 | 835.9 | 637.1 |
Total Assets | 24,273.7 | 21,210.4 | 23,657.5 | 19,886.7 | 19,979.1 | 19,838 | 14,551.8 | 12,537.3 | 8,434.3 | 7,204.3 |
Contingent Liabilities | 753.2 | 801.1 | 666.7 | 668 | 673.8 | 459.9 | 291.5 | 199 | 234.1 | 163.7 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 100.6 | 101.2 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 |
Reserves Total | 15,615.9 | 13,538.2 | 13,138.1 | 12,642.1 | 11,157.8 | 8,466.8 | 7,643.1 | 6,515.9 | 6,173.8 | 4,423 |
Total Shareholders Funds | 15,716.5 | 13,639.4 | 13,240.5 | 12,744.5 | 11,260.2 | 8,569.2 | 7,745.5 | 6,618.3 | 6,276.2 | 4,525.4 |
Secured Loans | 0 | 0 | 500 | 383.9 | 356.9 | 319.4 | 246.8 | 961.4 | 453.7 | 922.9 |
Unsecured Loans | 6,178.3 | 4,825.3 | 2,164.7 | 3,536 | 3,337.8 | 3,263.9 | 2,625.7 | 1,978.4 | 769.1 | 526.8 |
Total Debt | 6,178.3 | 4,825.3 | 2,664.7 | 3,919.9 | 3,694.7 | 3,583.3 | 2,872.5 | 2,939.8 | 1,222.8 | 1,449.7 |
Other Liabilities | 209.7 | 166.2 | 191.3 | 179.2 | 132.7 | 114.5 | 82.8 | 70.3 | 110.4 | 84.4 |
Total Liabilities | 22,104.5 | 18,630.9 | 16,096.5 | 16,843.6 | 15,087.6 | 12,267 | 10,700.8 | 9,628.4 | 7,609.4 | 6,059.5 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 8,677.4 | 7,999.8 | 7,675.6 | 7,009.1 | 6,564.2 | 6,152.3 | 4,515.7 | 3,896.3 | 3,720.5 | 3,118.9 |
Less : Accumulated Depreciation | 4,308 | 3,815.7 | 3,339.7 | 2,897.1 | 2,455.2 | 2,219.8 | 1,835.5 | 1,544.3 | 1,565.7 | 1,350.8 |
Net Block | 4,369.4 | 4,184.1 | 4,335.9 | 4,112 | 4,109 | 3,932.5 | 2,680.2 | 2,352 | 2,154.8 | 1,768.1 |
Capital Work in Progress | 633.9 | 739.3 | 384 | 570.5 | 552.6 | 674.9 | 659.2 | 678.4 | 296.8 | 366.9 |
Investments | 7,283 | 4,879.3 | 5,118 | 6,470.6 | 6,404.1 | 4,195.2 | 3,618.1 | 3,923.7 | 2,317.5 | 2,209.1 |
Inventories | 1,687.3 | 1,782.4 | 1,926.3 | 1,780 | 1,394.7 | 1,472.5 | 1,320.7 | 932.9 | 657.5 | 804.3 |
Sundry Debtors | 4,740.1 | 3,505.3 | 2,277.7 | 1,903.8 | 2,456.7 | 2,112.1 | 1,255.1 | 929 | 1,707.3 | 1,056.1 |
Cash and Bank Balance | 414.4 | 248.1 | 302.6 | 154 | 385.3 | 112.1 | 183.8 | 16.8 | 163.7 | 129.4 |
Loans and Advances | 1,069.5 | 1,420.8 | 2,110.3 | 2,193.9 | 556 | 560.6 | 797.8 | 260.7 | 293.9 | 249.2 |
Total Current Assets | 7,911.3 | 6,956.6 | 6,616.9 | 6,031.7 | 4,792.7 | 4,257.3 | 3,557.4 | 2,139.4 | 2,822.4 | 2,239 |
Current Liabilities | 1,669.2 | 1,539.3 | 1,384.5 | 1,401.7 | 1,195.1 | 1,157.9 | 1,217.3 | 1,283.7 | 1,074.3 | 814.8 |
Provisions | 252.8 | 199.1 | 105.9 | 111 | 70.5 | 89.6 | 52 | 29.8 | 54.9 | 339.5 |
Total Current Liabilities & Provisions | 1,922 | 1,738.4 | 1,490.4 | 1,512.7 | 1,265.6 | 1,247.5 | 1,269.3 | 1,313.5 | 1,129.2 | 1,154.3 |
Net Current Assets | 5,989.3 | 5,218.2 | 5,126.5 | 4,519 | 3,527.1 | 3,009.8 | 2,288.1 | 825.9 | 1,693.2 | 1,084.7 |
Deferred Tax Assets | 179.9 | 112 | 136.6 | 129.7 | 92.2 | 123.9 | 67 | 143.6 | 0 | 81.6 |
Deferred Tax Liability | 238.2 | 306.3 | 289.7 | 237 | 290.5 | 280.5 | 260.6 | 249.1 | 184.6 | 205.2 |
Net Deferred Tax | -58.3 | -194.3 | -153.1 | -107.3 | -198.3 | -156.6 | -193.6 | -105.5 | -184.6 | -123.6 |
Other Assets | 3,887.2 | 3,804.3 | 1,285.2 | 1,278.8 | 693.1 | 611.2 | 1,648.8 | 1,953.9 | 1,331.7 | 754.3 |
Total Assets | 22,104.5 | 18,630.9 | 16,096.5 | 16,843.6 | 15,087.6 | 12,267 | 10,700.8 | 9,628.4 | 7,609.4 | 6,059.5 |
Contingent Liabilities | 111 | 319.9 | 1,797.1 | 1,503.9 | 3,690.3 | 3,100.3 | 2,563.3 | 2,292 | 1,417.2 | 1,296 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 4,838.1 |
Depreciation | 764.1 |
Interest (Net) | -51.2 |
Dividend Received | 1.3 |
P/L on Sales of Assets | -13.4 |
Prov. and W/O (Net) | 61.1 |
P/L in Forex | -88.3 |
Others | -725 |
Total Adjustments (PBT and Ext... | 546.7 |
Operating Profit before Workin... | 5,384.8 |
Trade and 0ther Receivables | -747.2 |
Inventories | -2 |
Trade Payables | -44.8 |
Total Adjustments (OP before W... | -871.1 |
Cash Generated from/(used in) ... | 4,513.7 |
Direct Taxes Paid | -1,285.8 |
Total Adjustments(Cash Generat... | -1,285.8 |
Cash Flow before Extraordinary... | 3,227.9 |
Net Cash from Operating Activi... | 3,227.9 |
Purchased of Fixed Assets | -906.6 |
Sale of Fixed Assets | 23.7 |
Purchase of Investments | -106.7 |
Sale of Investments | 407.7 |
Interest Received | 127.4 |
Cancellation of Investment in ... | 55 |
Net Cash used in Investing Act... | -1,492.3 |
Proceed from 0ther Long Term B... | 1.4 |
Of the Long Tem Borrowings | -82.7 |
Of the Short Term Borrowings | -310.2 |
Dividend Paid | -621 |
Interest Paid | -72.9 |
Net Cash used in Financing Act... | -1,810.4 |
Net Profit before Tax and Extr... | 4,239.8 |
Depreciation | 504.4 |
Interest (Net) | 66.1 |
Dividend Received | 602.3 |
P/L on Sales of Assets | -13.6 |
Prov. and W/O (Net) | 49.2 |
P/L in Forex | -56.6 |
Others | -725 |
Total Adjustments (PBT and Ext... | -156 |
Operating Profit before Workin... | 4,083.8 |
Trade and 0ther Receivables | -1,255.1 |
Inventories | 95.1 |
Trade Payables | 90.9 |
Total Adjustments (OP before W... | -1,187 |
Cash Generated from/(used in) ... | 2,896.8 |
Direct Taxes Paid | -897.7 |
Total Adjustments(Cash Generat... | -897.7 |
Cash Flow before Extraordinary... | 1,999.1 |
Net Cash from Operating Activi... | 1,999.1 |
Purchased of Fixed Assets | -584.2 |
Sale of Fixed Assets | 18.8 |
Sale of Investments | 215.8 |
Interest Received | 295.1 |
Invest.In Subsidiaires | -2,670.7 |
Loans to Subsidiaires | -82.8 |
Cancellation of Investment in ... | 18.2 |
Net Cash used in Investing Act... | -1,830.6 |
Proceed from 0ther Long Term B... | 2,063.9 |
Of the Long Tem Borrowings | -360.8 |
Of the Short Term Borrowings | -352.3 |
Dividend Paid | -607.5 |
Interest Paid | -319.1 |
Net Cash used in Financing Act... | -300.8 |
Company Details
Registered Office |
|
Address | Zydus Corporate Park S No 536, Khoraj Sarkhej-Gandhinagar H/W |
City | Ahmedabad |
State | Gujarat |
Pin Code | 382481 |
Tel. No. | 91-079-26868100 |
Fax. No. | 91-079-26868337/26862365/26862366 |
dhavalsoni@zyduscadila.com; upen.shah@zyduscadila. | |
Internet | http://www.zyduscadila.com |
Registrars |
|
Address | Zydus Corporate Park S No 536 |
City | Ahmedabad |
State | Gujarat |
Pin Code | 382481 |
Tel. No. | 91-079-26868100 |
Fax. No. | 91-079-26868337/26862365/26862366 |
dhavalsoni@zyduscadila.com; upen.shah@zyduscadila. | |
Internet | http://www.zyduscadila.com |
Management |
|
Name | Designation |
Pankaj R Patel | Chairman (Non-Executive) |
Sharvil P Patel | Managing Director |
Mukesh M Patel | Non Executive Director |
Apurva S Diwanji | Independent Director |
Ganesh N Nayak | Whole-time Director |
Bhadresh K Shah | Independent Director |
Dhaval N Soni | Company Sec. & Compli. Officer |
Akhil A. Monappa | Independent Director |
Upasana Konidela. | Independent Director |
Shelina P. Parikh | Independent Director |